Reference number : 276-2023-2024-Q1-00035, amendment number : , agreement type : C, recipient legal name : Aqualitas Inc.|Aqualitas Inc., recipient country : CA, recipient province : NS, recipient city : Bedford|Bedford, recipient postal code : B4A 1E6, program name english : REGI - Strategic Growth Initiative (SGI), program name french : CERI - Initiative de croissance stratégique (ICS), program purpose english : nan, program purpose french : nan, agreement title english : 222169, agreement title french : 222169, agreement number : 222169, agreement value : 50000.0, agreement start date : 2023-05-02, agreement end date : 2024-03-31, description english : Support Master Drug File Application and participation in USFDA MAPS PTSD Clinical Study, description french : Soutenir demande dossier pharmac. principal/participer à étude clinique MAPS PTSD USFDA, expected results english : nan, expected results french : nan, additional information english : The assistance type is Non-Repayable Contribution., additional information french : Le type d'aide est contribution non remboursable., owner organization : acoa-apeca, owner organization title : Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique